Skip to main content
. 2021 Jun 9;60(11):1463–1473. doi: 10.1007/s40262-021-01036-8

Fig. 2.

Fig. 2

Goodness-of-fit plots for the final population pharmacokinetic model, coloured by country. Model-predicted population and individual paromomycin concentrations versus observed concentrations, and CWRES versus time after last dose and population predictions, for Kenya and Sudan (grey), Ethiopia (red) and India (blue). CWRES conditional weighted residuals